![]() |
市場調查報告書
商品編碼
2112460
超音波導針器:市場洞察、競爭格局及市場預測 - 2034 年Ultrasound Needle Guides - Market Insights, Competitive Landscape, and Market Forecast - 2034 |
||||||
超音波引導針是一種機械或追蹤附件,可安裝在超音波換能器上,在影像導引介入治療過程中為針頭建立固定且可預測的路徑。透過將針頭對準超音波波束平面,與無引導的徒手操作相比,引導針能夠縮短手術時間,改善針尖的即時可視化,減少重複插入試驗,並降低併發症風險。由於超音波導引介入治療廣泛應用於各種臨床場景,從床邊血管通路到前列腺和肝臟切片檢查實驗室,因此贊助商和醫院系統依賴於由專業配件製造商和各種超音波製造商提供的廣泛的生態系統,包括可重複使用的探頭支架、一次性使用的插入件和無菌手術包。此市場依產品類型分為可重複使用、一次性、無菌和非無菌引導針,依針頭引導機制分為平面內、平面外、角度可調和固定角度系統。此外,按應用領域分類,切片檢查引導針的應用包括活體組織切片、麻醉和神經阻斷、穿刺以及疼痛管理。按最終用戶分類,超音波導引針的應用包括醫院和診所,以及門診手術中心和影像診斷中心。在全球癌症和慢性疾病負擔日益加重、床邊超音波在門診和重症監護環境中的普及,以及人工智慧路徑規劃和電磁追蹤技術的不斷創新推動下,超音波引導針已成為支持安全高效的影像引導醫療的重要且常用的輔助設備。
超音波針導引器市場的主要市場促進因素
推動超音波針導引器市場成長的因素
市場促進因素
超音波導引介入手術數量增加
超音波導引針市場最強勁的促進因素是超音波導引診斷和介入手術數量的持續成長。超音波導引現已成為多種活體組織切片、液體抽吸、導管置入和局部麻醉手術的切片檢查,因為它無需使用電離輻射即可提供即時可視化,且成本低於CT或MRI引導。美國癌症協會預測,光是2025年美國就將新增200多例癌症病例,而每例診斷通常都需要透過影像導引切片檢查進行組織學確認。隨著腫瘤科、泌尿系統、肝病科和血管通路等領域手術數量的增加,可重複使用支架和一次性引導插片的消耗量將直接成長,從而推動市場在2034年之前持續成長。
慢性病盛行率不斷上升和人口老化
隨著癌症、心血管疾病和糖尿病等疾病在全球造成的負擔日益加重,人們對使用針頭導向器進行精準、微創介入治療的需求也日益成長。在老化且合併多種疾病的人群中,前列腺、肝臟、乳房和甲狀腺切片檢查,以及血管通路和透析導管置入術,都需要穩定的針道來減少併發症和試驗。隨著已開發市場和新興市場慢性病盛行率和老年人口的持續成長,引導式手術的數量和對相關配件的需求也相應增加,從而確保了長期的持續需求。
床邊超音波(POCUS)的快速普及
床邊超音波(POCUS)系統在急診醫學、重症監護、麻醉科和門診等領域的日益普及,正大大拓展針頭導引器的應用範圍,使其遠遠超出傳統放射科的範疇。 POCUS正支持非放射科醫師(這群人正在不斷壯大)在床邊進行血管通路、神經阻斷和穿刺操作。這些醫生依靠低成本、易於使用的一次性引導器來規範操作流程,並提高首次操作成功率。隨著POCUS平台在醫療機構的持續推廣,這種超音波引導操作的去中心化趨勢將在整個預測期內為引導器的銷售提供強勁的推動力。
市場限制因素
儘管超音波針導引器市場穩定成長,但仍面臨諸多限制因素。相容性分散源自於各超音波設備製造商之間針對不同探頭設計的支架和導向器種類繁多,迫使配件製造商維持龐大的產品線,並增加了多供應商醫院系統內部標準化的難度。在某些醫療機構,導向器的使用率有限,尤其是在經驗豐富的醫生中,他們更傾向於在某些高頻、低複雜度的操作中使用徒手技術。來自集團採購組織 (GPO) 的價格壓力和醫院採購整合正在擠壓通用一次性導向器的利潤空間。同時,不同地區和保險公司對引導操作的報銷標準也各不相同。嚴格的監管要求,包括針對每種探頭特定配置的 FDA 510(k) 批准和國際品質系統認證,正在延長產品開發週期並增加合規成本。在價格敏感的新興市場,高階、可追蹤和可重複使用的導向器普及緩慢,再加上在某些先進治療應用中來自機器人輔助和立體定向導航平台等替代導向技術的競爭,進一步限制了市場成長。儘管手術量增加、POCUS 的廣泛應用以及對感染控制的日益重視等強勁的潛在成長要素,但由於相容性、定價、監管和競爭等因素,市場擴張速度正在放緩。
Ultrasound Needle Guides Market Summary
An ultrasound needle guide is a mechanical or tracking-enabled accessory attached to an ultrasound transducer that establishes a fixed, predictable trajectory for a needle during image-guided interventional procedures. By keeping the needle aligned within the ultrasound beam plane, needle guides shorten procedure time, improve real-time needle-tip visualization, reduce the number of re-insertion attempts, and lower the risk of complications compared with unguided freehand technique. Because ultrasound-guided interventions span a wide range of clinical settings, from bedside vascular access to prostate and liver biopsy suites, sponsors and hospital systems rely on a broad ecosystem of probe-specific reusable brackets, single-use disposable inserts, and sterile procedure kits supplied by specialized accessory manufacturers and diversified ultrasound OEMs alike. The market is organized by product type across reusable, disposable, sterile, and non-sterile guides; by needle guidance mechanism across in-plane, out-of-plane, adjustable-angle, and fixed-angle systems; by application, led by biopsy procedures alongside anesthesia and nerve blocks, aspiration procedures, and pain management; and by end-user, led by hospitals and clinics alongside ambulatory surgical centers and diagnostic imaging centers. Driven by the rising global burden of cancer and chronic disease, the expansion of point-of-care ultrasound into outpatient and critical-care settings, and continuing innovation in AI-assisted trajectory mapping and electromagnetic tracking, ultrasound needle guides have become an essential, high-frequency accessory category underpinning safe and efficient image-guided care.
Ultrasound Needle Guides Market Key Growth Drivers
Key Companies in Ultrasound Needle Guides Market
The competitive landscape is led by the following active manufacturers:
Factors Contributing to the Growth of the Ultrasound Needle Guides Market
Market Drivers
Rising Volume of Ultrasound-Guided Interventional Procedures
The most powerful driver of the Ultrasound Needle Guides market is the sustained rise in ultrasound-guided diagnostic and interventional procedure volumes. Ultrasound guidance is now the clinical standard for a wide range of biopsies, fluid aspirations, catheter placements, and regional anesthesia procedures, because it delivers real-time visualization without ionizing radiation, at lower cost than CT or MRI guidance. The American Cancer Society projects more than 2 million new cancer diagnoses in the United States in 2025 alone, and each diagnostic pathway typically requires tissue confirmation through image-guided biopsy. As procedure volumes climb across oncology, urology, hepatology, and vascular access, the consumption of both reusable brackets and single-use guidance inserts rises directly, anchoring market growth through 2034.
Growing Prevalence of Chronic Disease and an Aging Population
The rising global burden of cancer, cardiovascular disease, and diabetes is expanding demand for precise, minimally invasive interventions that needle guides support. Prostate, liver, breast, and thyroid biopsies, along with vascular access and dialysis-catheter placement in an aging, comorbid population, depend on stable needle trajectories to reduce complications and repeat attempts. As chronic disease prevalence and the elderly population base continue to grow across developed and emerging markets alike, the underlying volume of guided procedures - and the accessories that support them - expands in step, sustaining durable long-term demand.
Rapid Expansion of Point-of-Care Ultrasound (POCUS)
The proliferation of compact, point-of-care ultrasound systems across emergency medicine, critical care, anesthesiology, and outpatient clinics is broadening the addressable base for needle guides well beyond traditional radiology suites. POCUS adoption supports bedside vascular access, nerve blocks, and aspiration procedures performed by a growing base of non-radiologist clinicians who rely on low-cost, easy-to-attach disposable guides to standardize technique and improve first-pass success. As POCUS platforms continue to proliferate across care settings, this decentralization of ultrasound-guided procedures is a structural tailwind for guide volumes through the forecast period.
Market Restraints
Despite steady momentum, the Ultrasound Needle Guides market faces material constraints. The proliferation of probe-specific bracket and guide designs across competing ultrasound OEMs creates compatibility fragmentation, requiring accessory manufacturers to maintain extensive product lines and complicating standardization for multi-vendor hospital systems. Clinician preference for unguided freehand technique in certain high-volume, low-complexity procedures, particularly among highly experienced operators, limits guide attachment rates in some settings. Pricing pressure from group purchasing organizations and hospital procurement consolidation compresses margins for commodity disposable guides, while reimbursement for the underlying guided procedures varies across geographies and payer systems. Stringent regulatory requirements, including FDA 510(k) clearance and international quality-system certification for each probe-specific configuration, lengthen product-development timelines and raise compliance costs. Slower adoption of premium tracking-enabled and reusable guide categories in price-sensitive and emerging markets, combined with competition from alternative guidance technologies such as robotic-assisted and stereotactic navigation platforms in select high-acuity applications, further tempers growth. Together, these compatibility, pricing, regulatory, and competitive dynamics moderate the pace of expansion, even as the underlying drivers of procedure-volume growth, POCUS adoption, and infection-control preference remain firmly intact.
Ultrasound Needle Guides Market Segment Analysis
The ultrasound needle guides market by product type (reusable ultrasound needle guides, disposable ultrasound needle guides, sterile ultrasound needle guides, non-sterile ultrasound needle guides), needle guidance mechanism (in-plane needle guides, out-of-plane needle guides, adjustable-angle needle guides, fixed-angle needle guides), application (anesthesia & nerve blocks, biopsy procedures, aspiration procedures, pain management, others), end-users (hospitals & clinics, ambulatory surgical centers (ascs), diagnostic imaging centers, others), and geography (North America, Europe, Asia-Pacific, and Rest of World).
By Product Type
Dominant Subsegment: Disposable Ultrasound Needle Guides.
The disposable ultrasound needle guides segment accounted for approximately 74% of the Ultrasound Needle Guides market in 2025. Disposable guides are the leading product type because hospitals and ambulatory facilities increasingly prioritize infection control and eliminate the labor, cost, and turnaround burden of reprocessing between procedures. The two-part design popularized by systems such as CIVCO's Ultra-Pro II, pairing a durable, probe-specific reusable bracket with a sterile, single-use snap-on guide, allows facilities to combine cost efficiency with per-procedure sterility assurance. High-frequency applications such as vascular access, fine-needle aspiration, and regional anesthesia particularly favor disposables given their procedure volume and turnaround requirements. While reusable guides are growing at the fastest rate as tracking-enabled and premium multi-angle systems gain clinical traction in specialized biopsy and interventional-radiology settings, the sheer procedure volume and infection-control preference secure the disposable segment's leadership across the forecast period.
By Needle Guidance Mechanism
Dominant Subsegment: In-Plane Needle Guides.
The in-plane needle guides segment accounted for approximately 57% of the Ultrasound Needle Guides market in 2025. In-plane guidance is the leading mechanism because it keeps the entire needle shaft and tip continuously visible within the ultrasound beam plane throughout advancement, which is the preferred technique for regional anesthesia and nerve block procedures, vascular access, and many superficial biopsy applications where continuous needle-tip visualization is critical to safety. Clinical training programs and professional society guidelines widely favor in-plane technique for novice and experienced operators alike, reinforcing its adoption across hospitals and outpatient settings. Adjustable-angle guides are the fastest-growing mechanism, as they allow clinicians to modify needle trajectory without withdrawing and repositioning the instrument, an increasingly valued feature in prostate and deep-organ biopsy. Out-of-plane and fixed-angle guides retain steady niche demand in specific deep-target and endocavity applications. Nonetheless, the versatility and safety profile of in-plane guidance secure its leadership across the forecast period.
Ultrasound Needle Guides Market Region Analysis
Dominant Region: North America
North America accounted for 36% of the global Ultrasound Needle Guides market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a mature interventional-radiology and point-of-care ultrasound ecosystem, high per-capita procedure volumes, a dense hospital and ambulatory surgical center network, and clear FDA 510(k) regulatory pathways, particularly in the United States. North America hosts the largest installed base of ultrasound systems from GE HealthCare, Siemens Healthineers, and other major OEMs, and benefits from proximity to leading accessory manufacturers such as CIVCO Medical Solutions, Aspen Surgical, and Argon Medical Devices. Rising cancer screening rates, growing adoption of the transperineal prostate biopsy approach, and expanding point-of-care ultrasound use across emergency medicine and critical care drive substantial guide consumption. Strong reimbursement for image-guided procedures, well-established clinician training infrastructure, and continued product innovation anchor the region's continued leadership across the forecast period.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the Ultrasound Needle Guides market. The region's elevated CAGR is driven by rising cancer incidence, rapid expansion of hospital and diagnostic imaging infrastructure, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China is expanding its base of installed ultrasound systems and interventional-radiology capacity, Japan is advancing point-of-care ultrasound adoption in outpatient and critical-care settings, India is scaling low-cost biopsy and diagnostic imaging services alongside a growing base of ambulatory surgical centers, and South Korea and Australia are adopting premium tracking-enabled guidance systems in leading academic hospitals. Government healthcare investment, an expanding oncology patient population, and growing local manufacturing by regional OEMs such as Mindray are accelerating adoption, while regional distributors increasingly partner with global accessory manufacturers to broaden probe-specific coverage. The combination of high disease burden, infrastructure build-out, and rising POCUS penetration positions Asia-Pacific as the principal source of incremental growth over the forecast period.
Regional Commentary
North America
North America accounted for 36% of the global Ultrasound Needle Guides market revenue in 2025. The United States dominates on the strength of its interventional-radiology infrastructure, POCUS adoption, FDA regulatory clarity, and proximity to leading accessory manufacturers, while growing transperineal prostate biopsy adoption and expanding point-of-care ultrasound use across emergency and critical care reinforce its leadership.
Europe
Europe is a large and advanced regional market, supported by well-established interventional-radiology and anesthesiology practice, harmonized CE-marking regulatory pathways, and strong clinical adoption of ultrasound-guided regional anesthesia. Product launches and platform-embedded guidance software from Siemens Healthineers and Esaote, alongside distribution reach from CIVCO and Rocket Medical, reinforce the region's role in supplying both hospital and ambulatory procedure settings across Germany, France, the United Kingdom, Italy, and Spain.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by rising cancer incidence, rapid hospital and diagnostic imaging infrastructure build-out, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China's expanding installed ultrasound base, Japan's POCUS adoption, India's low-cost diagnostic imaging scale-up, and growing regional manufacturing by Mindray are accelerating regional guide consumption and clinical-training activity.
Rest of World
The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital and diagnostic imaging infrastructure, rising demand for image-guided biopsy and anesthesia procedures, and gradual alignment of regulatory frameworks with international standards are broadening access, while distributor partnerships with global manufacturers support the build-out of regional procedure capacity.
Ultrasound Needle Guides Market Competitive Landscape
The Ultrasound Needle Guides market is classified as Fragmented. A group of specialized accessory manufacturers with broad probe-compatible portfolios, including CIVCO Medical Solutions, Aspen Surgical, and Argon Medical Devices, hold leading positions through extensive OEM-compatible product lines, while diversified ultrasound system OEMs, including GE HealthCare, Siemens Healthineers, Mindray, and Esaote, compete by embedding guidance and tracking capability directly into their imaging platforms. Focused device makers such as Geotek Medical, Rocket Medical, Becton, Dickinson and Company (BD), and Veran Medical Technologies compete through specialized bracket systems, vascular-access integration, and electromagnetic tracking expertise, respectively, intensifying competition across both the commodity disposable and premium tracking-enabled segments.
The competitive landscape can be evaluated across the following dimensions:
Ultrasound Needle Guides Market Recent Developmental Activities
In 2026, CIVCO Medical Solutions expanded its TP Pivot Pro transperineal biopsy guide portfolio and continued rollout of the Verza and VerzaLink multi-angle needle guidance systems across additional ultrasound transducer families. Strategic significance: Broadens freehand, infection-reducing transperineal biopsy access and reinforces CIVCO's position as the leading probe-compatible accessory provider.
In 2026, Siemens Healthineers acquired a niche needle-tracking technology firm to embed AI-assisted trajectory-mapping software into its Acuson ultrasound platform. Strategic significance: Strengthens platform-embedded guidance capability and extends Siemens Healthineers' premium, tracking-enabled offering.
Ultrasound Needle Guides Market Segmentation
Ultrasound Needle Guides Market by Product Type
Ultrasound Needle Guides Market by Needle Guidance Mechanism
Ultrasound Needle Guides Market by Application
Ultrasound Needle Guides Market by End-Users
Ultrasound Needle Guides Market by Geography
Key Takeaways from the Ultrasound Needle Guides Market Report Study
Target audience who can benefit from this ultrasound needle guides market report study
Q1. What is the growth rate of the ultrasound needle guides market?
The ultrasound needle guides market is projected to expand at a CAGR of 6.2% during the forecast period from 2026-2034.
Q2. What is the market size of the ultrasound needle guides market?
The ultrasound needle guides market is estimated at USD 398 million in 2025 and is projected to reach USD 682 million by 2034.
Q3. Which region dominates the ultrasound needle guides market?
North America dominated the Ultrasound Needle Guides market with a 36% share of global revenue in 2025, supported by a mature interventional-radiology and point-of-care ultrasound ecosystem, high per-capita procedure volumes, FDA regulatory clarity, and proximity to leading accessory manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the ultrasound needle guides market?
The principal drivers are the rising global volume of ultrasound-guided interventional procedures, supported by more than 2 million projected new U.S. cancer diagnoses in 2025; the growing prevalence of chronic disease and an aging population; rapid expansion of point-of-care ultrasound (POCUS) across critical care and outpatient settings; rising prostate biopsy incidence and transperineal biopsy adoption; the structural shift toward single-use, infection-controlled accessories; and continuing innovation in AI-assisted and tracking-enabled guidance.
Q5. Who are the major players in the ultrasound needle guides market?
The major players include CIVCO Medical Solutions, Aspen Surgical, Geotek Medical, Rocket Medical, Mindray, Esaote, GE HealthCare, Siemens Healthineers, Becton, Dickinson and Company (BD), and Argon Medical Devices, among other active providers profiled in the Competitive Landscape section, along with Veran Medical Technologies. CIVCO Medical Solutions, Aspen Surgical, and Argon Medical Devices lead through broad probe-compatible product portfolios.
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.